4.3 Article

Guidelines for the management of hemophilia

Journal

HAEMOPHILIA
Volume 19, Issue 1, Pages E1-E47

Publisher

WILEY
DOI: 10.1111/j.1365-2516.2012.02909.x

Keywords

bleeding disorders; guidelines; hemophilia; management; treatment

Categories

Funding

  1. Bayer Hemophilia Awards Program
  2. Baxter
  3. Novo Nordisk
  4. Bayer
  5. CSL Behring
  6. Wyeth

Ask authors/readers for more resources

Hemophilia is a rare disorder that is complex to diagnose and to manage. These evidence-based guidelines offer practical recommendations on the diagnosis and general management of hemophilia, as well as the management of complications including musculoskeletal issues, inhibitors, and transfusion-transmitted infections. By compiling these guidelines, the World Federation of Hemophilia aims to assist healthcare providers seeking to initiate and/or maintain hemophilia care programs, encourage practice harmonization around the world and, where recommendations lack adequate evidence, stimulate appropriate studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available